AZIZ SHAIBANI to Male
This is a "connection" page, showing publications AZIZ SHAIBANI has written about Male.
Connection Strength
0.145
-
Refractory Chronic Immune-mediated Demyelinating Polyneuropathy. Neurol Clin. 2020 08; 38(3):591-605.
Score: 0.022
-
Swallowing-induced Supraventricular Tachyarrhythmia. Rev Cardiovasc Med. 2017; 18(1):53-58.
Score: 0.017
-
Distal Myopathies: Case Studies. Neurol Clin. 2016 Aug; 34(3):547-64.
Score: 0.017
-
Autosomal recessive posterior column ataxia with retinitis pigmentosa caused by novel mutations in the FLVCR1 gene. Int J Neurosci. 2015 Jan; 125(1):43-9.
Score: 0.014
-
Efficacy and safety of dextromethorphan/quinidine at two dosage levels for diabetic neuropathic pain: a double-blind, placebo-controlled, multicenter study. Pain Med. 2012 Feb; 13(2):243-54.
Score: 0.012
-
Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial. J Pain. 2009 Aug; 10(8):818-28.
Score: 0.010
-
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911.
Score: 0.007
-
Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. Neurology. 2021 03 23; 96(12):e1595-e1607.
Score: 0.006
-
Gene therapy for diabetic peripheral neuropathy: A randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin Transl Sci. 2021 05; 14(3):1176-1184.
Score: 0.006
-
Minimal manifestation status and prednisone withdrawal in the MGTX trial. Neurology. 2020 08 11; 95(6):e755-e766.
Score: 0.005
-
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Lancet Neurol. 2019 09; 18(9):834-844.
Score: 0.005
-
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI. Neurology. 2018 06 05; 90(23):e2034-e2041.
Score: 0.005
-
Moving toes and myoclonus associated with hereditary neuropathy with liability to pressure palsy (HNPP). Muscle Nerve. 1997 Jul; 20(7):881-3.
Score: 0.004
-
Randomized Trial of Thymectomy in Myasthenia Gravis. N Engl J Med. 2016 08 11; 375(6):511-22.
Score: 0.004
-
Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst. 2015 Dec; 20(4):363-71.
Score: 0.004
-
Clinical and biochemical improvement of very long-chain acyl-CoA dehydrogenase deficiency in pregnancy. J Perinatol. 2010 Aug; 30(8):558-62.
Score: 0.003
-
Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study. Clin J Pain. 2007 Feb; 23(2):150-8.
Score: 0.002
-
Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study. Acta Neurol Scand. 2006 Jun; 113(6):395-404.
Score: 0.002